Kang Enbei acquires the property rights of new oral treatment drugs for 100 million yuan to enrich its large health product line


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login